Bupivacaine Hydrochloride NDC 31722-275

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-275Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0275Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
31722-275-31	31722027531	10 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-31) / 10 mL in 1 VIAL, SINGLE-DOSE (31722-275-10)Marketed from Mar 27, 2024
31722-275-32	31722027532	25 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-32) / 10 mL in 1 VIAL, SINGLE-DOSE (31722-275-10)Marketed from Mar 27, 2024
31722-275-33	31722027533	10 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-33) / 30 mL in 1 VIAL, SINGLE-DOSE (31722-275-30)Marketed from Mar 27, 2024
31722-275-34	31722027534	25 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-34) / 30 mL in 1 VIAL, SINGLE-DOSE (31722-275-30)Marketed from Mar 27, 2024
31722-275-35	31722027535	50 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-35) / 30 mL in 1 VIAL, SINGLE-DOSE (31722-275-30)Marketed from Mar 27, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupivacaine Hydrochloride
Generic name (nonproprietary): bupivacaine hydrochloride
Active ingredients: Bupivacaine hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration, Intracaudal, Perineural
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217821
Marketing start: Mar 27, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 31722-275_4ea16f8e-77de-3ba7-e063-6394a90a5667SPL ID 4ea16f8e-77de-3ba7-e063-6394a90a5667SPL set ID 0e552e3a-cf52-4d74-9381-6cc1b29b4c90RxCUI 1724786, 1724787, 1724880, 1724884, 1725078, 1725082UNII 7TQO7W3VT8UPC 0331722276306, 0331722276108, 0331722275101, 0331722277303, 0331722277105, 0331722275309
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N431722027531 followed by a unit qualifier and the quantity

Package 31722-0275-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 4, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of bupivacaine hydrochloride injection is recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see Dosage and Administration (2.2) ]. Limitations of Use Not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use [see Dosage and Administration (2.2) , Contraindications (4) , Warnings and Precaut…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217821

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217821
Product	Strength	Form · route	Labeler	Product NDC
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	NorthStar RxLLC	72603-327
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 2.5 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	NorthStar RxLLC	72603-415
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionEpidural, Intracaudal, Perineural	NorthStar RxLLC	72603-506
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 7.5 mg/mL	Injection, SolutionEpidural, Retrobulbar	Camber Pharmaceuticals, Inc.	31722-277
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionEpidural, Intracaudal, Perineural	Camber Pharmaceuticals, Inc.	31722-276
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 5 mg/mL	Injection, SolutionEpidural, Intracaudal, Perineural	NorthStar RxLLC	72603-602
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 7.5 mg/mL	Injection, SolutionEpidural, Retrobulbar	NorthStar RxLLC	72603-700
Bupivacaine Hydrochloride	Bupivacaine hydrochloride 7.5 mg/mL	Injection, SolutionEpidural, Retrobulbar	NorthStar RxLLC	72603-800